| Pharmacology of levosimendan: inotropic, vasodilatory and cardioprotective effects A Pathak, M Lebrin, A Vaccaro, JM Senard, F Despas Journal of clinical pharmacy and therapeutics 38 (5), 341-349, 2013 | 167 | 2013 |
| Dual agonist occupancy of AT1-R–α2C-AR heterodimers results in atypical Gs-PKA signaling M Bellot, S Galandrin, C Boularan, HJ Matthies, F Despas, C Denis, ... Nature chemical biology 11 (4), 271-279, 2015 | 108 | 2015 |
| Overview of drug data within French health insurance databases and implications for pharmacoepidemiological studies A Palmaro, G Moulis, F Despas, J Dupouy, M Lapeyre‐Mestre Fundamental & clinical pharmacology 30 (6), 616-624, 2016 | 95 | 2016 |
| High-intensity interval exercise improves vagal tone and decreases arrhythmias in chronic heart failure T Guiraud, M Labrunee, K Gaucher-Cazalis, F Despas, P Meyer, ... Medicine & science in sports & exercise 45 (10), 1861-1867, 2013 | 93 | 2013 |
| What is pharmacoepidemiology? Definition, methods, interest and clinical applications JL Montastruc, J Benevent, F Montastruc, H Bagheri, F Despas, ... Therapies 74 (2), 169-174, 2019 | 89 | 2019 |
| Intracranial pressure is a determinant of sympathetic activity EA Schmidt, F Despas, A Pavy-Le Traon, Z Czosnyka, JD Pickard, ... Frontiers in physiology 9, 11, 2018 | 89 | 2018 |
| Peripheral chemoreflex activation contributes to sympathetic baroreflex impairment in chronic heart failure F Despas, E Lambert, A Vaccaro, M Labrunee, N Franchitto, M Lebrin, ... Journal of hypertension 30 (4), 753-760, 2012 | 84 | 2012 |
| Direct evidences for sympathetic hyperactivity and baroreflex impairment in Tako Tsubo cardiopathy A Vaccaro, F Despas, C Delmas, O Lairez, E Lambert, G Lambert, ... PloS one 9 (3), e93278, 2014 | 70 | 2014 |
| Abatacept in rheumatoid arthritis and the risk of cancer: a world observational post-marketing study S de Germay, H Bagheri, F Despas, V Rousseau, F Montastruc Rheumatology 59 (9), 2360-2367, 2020 | 56 | 2020 |
| Excessive sympathetic activation in heart failure with chronic renal failure: role of chemoreflex activation F Despas, N Detis, N Dumonteil, M Labrunee, B Bellon, N Franchitto, ... Journal of hypertension 27 (9), 1849-1854, 2009 | 52 | 2009 |
| Pulmonary arterial hypertension associated with protein kinase inhibitors: a pharmacovigilance–pharmacodynamic study L Cornet, C Khouri, M Roustit, C Guignabert, MC Chaumais, M Humbert, ... European Respiratory Journal 53 (5), 2019 | 48 | 2019 |
| Renal sympathetic nerve denervation using intraluminal ultrasound within a cooling balloon preserves the arterial wall and reduces sympathetic nerve activity. A Pathak, L Coleman, A Roth, J Stanley, L Bailey, P Markham, S Ewen, ... EuroIntervention: journal of EuroPCR in collaboration with the Working Group …, 2015 | 45 | 2015 |
| Bortezomib and heart failure: case‐report and review of the French P harmacovigilance database B Honton, F Despas, N Dumonteil, C Rouvellat, M Roussel, D Carrie, ... Fundamental & clinical pharmacology 28 (3), 349-352, 2014 | 42 | 2014 |
| Microtubule-driven stress granule dynamics regulate inhibitory immune checkpoint expression in T cells DM Franchini, O Lanvin, M Tosolini, EP de Campaigno, A Cammas, ... Cell Reports 26 (1), 94-107. e7, 2019 | 41 | 2019 |
| Transcatheter aortic valve implantation reduces sympathetic activity and normalizes arterial spontaneous baroreflex in patients with aortic stenosis N Dumonteil, A Vaccaro, F Despas, M Labrunee, B Marcheix, E Lambert, ... JACC: Cardiovascular Interventions 6 (11), 1195-1202, 2013 | 41 | 2013 |
| Tonic chemoreflex activation contributes to increased sympathetic nerve activity in heart failure–related anemia N Franchitto, F Despas, M Labrunée, J Roncalli, S Boveda, M Galinier, ... Hypertension 55 (4), 1012-1017, 2010 | 41 | 2010 |
| Ephrin-B1 is a novel specific component of the lateral membrane of the cardiomyocyte and is essential for the stability of cardiac tissue architecture cohesion G Genet, C Guilbeau-Frugier, B Honton, E Dague, MD Schneider, ... Circulation research 110 (5), 688-700, 2012 | 39 | 2012 |
| Acute electromyostimulation decreases muscle sympathetic nerve activity in patients with advanced chronic heart failure (EMSICA Study) M Labrunée, F Despas, P Marque, T Guiraud, M Galinier, JM Senard, ... PLoS One 8 (11), e79438, 2013 | 36 | 2013 |
| Identification of cellular targets involved in cardiac failure caused by PKI in oncology: an approach combining pharmacovigilance and pharmacodynamics E Patras de Campaigno, E Bondon‐Guitton, G Laurent, F Montastruc, ... British Journal of Clinical Pharmacology 83 (7), 1544-1555, 2017 | 32 | 2017 |
| Ambulatory Medical Assistance-After Cancer (AMA-AC): A model for an early trajectory survivorship survey of lymphoma patients treated with anthracycline-based chemotherapy G Compaci, M Rueter, S Lamy, L Oberic, C Recher, M Lapeyre-Mestre, ... BMC cancer 15, 1-13, 2015 | 29 | 2015 |
Senard JMVerified email at univ-tlse3.fr
